On July 22, a motion was filed requesting a new multidistrict litigation (MDL) for lawsuits alleging that Sanofi SA’s chemotherapy drug, Taxotere, can cause permanent hair loss, particularly in those being treated for breast cancer. Multidistrict litigation is a special procedure in which federal civil (noncriminal) cases from around the country are transferred to one...
TAXOTERE PERMANENT HAIR LOSS LAWSUITS COULD BECOME AN MDL (MULTIDISTRICT LITIGATION)
